Ludwig-Maximilians-Universität (LMU)

Effects of Marathon Running on Cognition and Retinal Vascularization: A Longitudinal Observational Study (2021) Roeh A, Schoenfeld J, Raab R, Landes V, Papazova I, Haller B, Strube W, et al. Journal article Value of PET imaging for radiation therapy Wertigkeit der PET-Bildgebung für die Radioonkologie (2021) Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, et al. Journal article, Review article IMMUNOMONITORING OF CD19. CAR T-CELLS IN LARGE B-CELL LYMPHOMA- A TWO-CENTER EXPERIENCE (2021) Blumenberg V, Völkl S, Busch G, Baumann S, Winkelmann M, Tast B, Nixdorf D, et al. Conference contribution Association of the retinal vasculature and intrathecal immunity during relapsing remitting multiple sclerosis (2021) Noll C, Aly L, Hiltensperger M, Wicklein R, Mitsdorffer M, Herrmann D, Gasperi C, et al. Conference contribution DIVERSITY OF CD4(+) BLOOD T-CELL CLONALITY PREDICTS LONGER SURVIVAL WITH CTLA4 OR PD-1 CHECKPOINT INHIBITION IN ADVANCED MELANOMA (2021) Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt M, Berking C, Prinz JC Conference contribution Roadmap on organic-inorganic hybrid perovskite semiconductors and devices (2021) Schmidt-Mende L, Dyakonov V, Olthof S, Ünlü F, Lê KMT, Mathur S, Karabanov AD, et al. Journal article Spectrum bias and individual strengths of SARS-CoV-2 serological tests–A population-based evaluation (2021) Einhauser S, Peterhoff D, Niller HH, Beileke S, Günther F, Steininger P, Burkhardt R, et al. Journal article TYK2-Inhibition: Potenzial bei der Behandlung chronisch-entzündlicher Immunerkrankungen (2021) Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, et al. Journal article, Review article NanoString technology distinguishes anti-TIF-1g+from anti-Mi-2+dermatomyositis patients (2021) Preusse C, Eede P, Heinzerling L, Freitag K, Koll R, Froehlich W, Schneider U, et al. Journal article Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT) (2021) Tufman A, Neumann J, Manapov F, Sellmer L, Jung A, Kauffmann-Guerrero D, Kahnert K, et al. Journal article